These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 12468550)
1. New insights into the tPA-annexin A2 interaction. Is annexin A2 CYS8 the sole requirement for this association? Roda O; Valero ML; Peiró S; Andreu D; Real FX; Navarro P J Biol Chem; 2003 Feb; 278(8):5702-9. PubMed ID: 12468550 [TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. Hajjar KA; Mauri L; Jacovina AT; Zhong F; Mirza UA; Padovan JC; Chait BT J Biol Chem; 1998 Apr; 273(16):9987-93. PubMed ID: 9545344 [TBL] [Abstract][Full Text] [Related]
3. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin. MacLeod TJ; Kwon M; Filipenko NR; Waisman DM J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231 [TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. Siao CJ; Tsirka SE J Neurosci; 2002 May; 22(9):3352-8. PubMed ID: 11978811 [TBL] [Abstract][Full Text] [Related]
6. Binding of tissue plasminogen activator to endothelial cells. The effect on functional properties. Localization of a ligand in the B-chain of tPA. Cheng XF; Brohlin M; Pohl G; Bäck O; Wallén P Thromb Res; 1995 Jan; 77(2):149-64. PubMed ID: 7740507 [TBL] [Abstract][Full Text] [Related]
7. Annexin II: a mediator of the plasmin/plasminogen activator system. Hajjar KA; Krishnan S Trends Cardiovasc Med; 1999 Jul; 9(5):128-38. PubMed ID: 10639727 [TBL] [Abstract][Full Text] [Related]
8. Profibrinolytic properties characterize a stably transformed human endothelial cell line. Camera M; Hajjar KA; Pan S; Szabo P; Vicart P; Paulin D; Weksler BB Blood Coagul Fibrinolysis; 1998 Mar; 9(2):153-65. PubMed ID: 9622213 [TBL] [Abstract][Full Text] [Related]
9. Annexin A2 in primary afferents contributes to neuropathic pain associated with tissue type plasminogen activator. Yamanaka H; Kobayashi K; Okubo M; Noguchi K Neuroscience; 2016 Feb; 314():189-99. PubMed ID: 26642807 [TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2. Ortiz-Zapater E; Peiró S; Roda O; Corominas JM; Aguilar S; Ampurdanés C; Real FX; Navarro P Am J Pathol; 2007 May; 170(5):1573-84. PubMed ID: 17456763 [TBL] [Abstract][Full Text] [Related]
11. Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects. Kesavan K; Ratliff J; Johnson EW; Dahlberg W; Asara JM; Misra P; Frangioni JV; Jacoby DB J Biol Chem; 2010 Feb; 285(7):4366-74. PubMed ID: 20018898 [TBL] [Abstract][Full Text] [Related]
12. A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. Valapala M; Thamake SI; Vishwanatha JK J Cell Sci; 2011 May; 124(Pt 9):1453-64. PubMed ID: 21486955 [TBL] [Abstract][Full Text] [Related]
13. Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase. Lin L; Wu C; Hu K J Am Soc Nephrol; 2012 Aug; 23(8):1329-38. PubMed ID: 22677557 [TBL] [Abstract][Full Text] [Related]
14. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. Hajjar KA; Jacovina AT; Chacko J J Biol Chem; 1994 Aug; 269(33):21191-7. PubMed ID: 8063740 [TBL] [Abstract][Full Text] [Related]
15. Interaction of tissue plasminogen activator with a human endothelial cell 45-kilodalton plasminogen receptor. Dudani AK; Pluskota A; Ganz PR Biochem Cell Biol; 1994; 72(3-4):126-31. PubMed ID: 7818846 [TBL] [Abstract][Full Text] [Related]
16. Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces. Tsunezumi J; Yamamoto K; Higashi S; Miyazaki K FEBS J; 2008 Oct; 275(19):4810-23. PubMed ID: 18721140 [TBL] [Abstract][Full Text] [Related]
17. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Kwon M; MacLeod TJ; Zhang Y; Waisman DM Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370 [TBL] [Abstract][Full Text] [Related]